FACULTY:
Jim Brookshier, MPO is the Clinical Director of the Cranial Remolding Program at UT Health San Antonio.
OVERVIEW:
In this episode host Holly Wayment talks with Jim Brookshier, Clinical Director of the Cranial Remolding Program at UT Health San Antonio, about diagnosing and treating infant head shape abnormalities.
They cover common conditions like plagiocephaly and brachycephaly, how to distinguish positional deformity from craniosynostosis, the ideal four-to-six month treatment window for helmet therapy, imaging options, adherence tips, and emerging technologies such as 3D scanning, 3D printing, and AI — plus recent Medicaid coverage changes.
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Speaker: Jim Brookshier, MPO has no relevant financial relationships with ineligible companies to disclose.
The Pediatrics Now Podcast Planning Committee members: Steven Seidner, MD, and Holly Wayment have no relevant financial relationships with ineligible companies to disclose.
The University of Texas at San Antonio and Steven Seidner, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas at San Antonio designates this enduring material up to a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
10/2/2026
EXPIRATION DATE:
8/31/2029